BioCentury
ARTICLE | Company News

Wilex, RedHill deal

July 14, 2014 7:00 AM UTC

Wilex granted RedHill exclusive rights to develop and commercialize Mesupron outside of Taiwan and China, including Hong Kong and Macau. Wilex will receive $1 million up front and is eligible for tie...